Estimating the client costs of addiction treatment: first findings from the client drug abuse treatment cost analysis program (Client DATCAP)

Out of touch or on the money: Do the clinical objectives of addiction treatment coincide with economic evaluation results?

“…Third, some intangible economic costs were not quantified, which may have caused an underestimation of total costs to society. Addiction treatment costs may also be underestimated to the extent that patient-specific costs such as travel expenses and opportunity costs of time in treatment were not included (Salomé, French, Miller, & McLellan, 2003). As noted above, no value can be readily placed on the core clinical outcome of reduced days of substance use.…”

A research agenda for economic evaluation of substance abuse services

“…The vast majority of research on the economic consequences and costs of substance abuse has been conducted using adult samples Salomé et al, 2003). The same can be said about CEAs and BCAs of addiction interventions (Fleming et al, 2000(Fleming et al, , 2002French, Salomé, & Carney, 2002;Zaric et al, 2000).…”

“…The data collected from treatment providers are used to estimate the opportunity costs of all treatment resources, including personnel, facilities, supplies, and materials French, Roebuck, & McLellan, 2004;Roebuck et al, 2003). Salomé et al (2003) introduced the Client DATCAP, a standardized, self-administered instrument, to measure the costs incurred by individuals receiving treatment. The DATCAP family of instruments (Program, Brief, and Client) enables researchers and treatment providers to estimate the costs of treatment more accurately and to compare different programs www.DATCAP.com).…”

A critical review of accounting and economic methods for estimating the costs of addiction treatment

“…Salome, French, Miller, and McLellan (2003) extended the data collection method to costs incurred by clients in treatment. Intended for self-administration, questions are solicited to find the cost to the patient of time in treatment, cash or in-kind payments by patients to attend treatment, incurred costs of attending treatment (such as the dependent care of paring fees), and, finally, the total cost that the patient faces.…”